Loading...
Please wait, while we are loading the content...
Similar Documents
Field Evaluation and Use of a Non Commercial Peptide Enzyme Immunoassay for Human Immunodeficiency Virus Serotyping in Abidjan ( Ivory Coast )
| Content Provider | Semantic Scholar |
|---|---|
| Author | Inwoley, André Affi-Aboli Barin, A. |
| Copyright Year | 2017 |
| Abstract | The fight against this pandemic needs simultaneous use of effective preventive action and wider access to treatment. However, in the absence of vaccine, fighting activities focus firstly on prevention through awareness of infection status and secondly on a better therapeutic management of infected persons. Given its importance in struggling against AIDS, biological diagnosis of HIV infection is importance and is based on the detection of antibodies in adults and children over 18 months. The “conventional” strategy associates antibody screening by one or more enzyme-linked immunosorbent assays (ELISA), and a confirmation of positive results with Western blot. This strategy is not always feasible in developing countries for many reasons. Indeed, this strategy The PBEIA uses peptides representative of the immunodominant regions of the transmembrane glycoprotein and the surface glycoprotein (V3 loop) of both HIV-1 (gp41 and V3.1) and HIV-2 (gp36 and V3.2). The evaluation of this assay was carried out using: 510 serum samples including 200 from HIV-negative individuals and 310 from HIV-positive individuals (130 HIV-1,105 HIV-2 and 75 HIV with dual seroreactivity) based on results obtained and 145 other samples positive for HIV-2. Murex HIV-1.2.OTM, Vironostika HIV Uni-Form II plus OTM and western blot tests were used as reference gold standard assays. |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | http://www.annexpublishers.co/articles/JIID/4104-Field-Evaluation-and-Use-of-a-Non-Commercial-Peptide-Enzyme-Immunoassay-for-Human-Immunodeficiency-Virus-Serotyping-in-Abidjan-Ivory-Coast.pdf |
| Language | English |
| Access Restriction | Open |
| Subject Keyword | Acquired Immunodeficiency Syndrome Dual Enzyme Immunoassay Enzyme-Linked Immunosorbent Assay Fulvophyton murex GPNMB gene HIV Infections Human immunodeficiency virus 2 (HIV-2) Immunodominant Epitopes Immunologic Deficiency Syndromes Membrane Glycoproteins Operations and technology management V3 Loop Virtual screening Western Blot Western Blotting confirmation - ResponseLevel |
| Content Type | Text |
| Resource Type | Article |
